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Synopsis: Patients with resection for stage IV colorectal cancer have an increased 
anastomotic leak rate. 
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Abstract 
Purpose: To investigate if metastatic colorectal cancer (UICC stage IV disease) 
represents a risk factor for anastomotic leakage after colorectal surgery without major 
hepatic resection. 
 
Methods: This retrospective cohort study is based on an existing prospective 
colorectal database with all consecutive colorectal resections done at the authors’ 
institution from 07/2002 to 07/2012 (n=2104). All patients with colorectal resection 
and primary anastomosis for colorectal cancer were identified (n=500). A temporary 
loop ileostomy was constructed in low rectal anastomosis up to 6 cm from anal verge 
(n=128 cases; 26%). Routine contrast enema was done at the occasion of other 
prospective studies (n=254). UICC stage IV disease was present in n=94 patients 
(19%), while n=406 (81%) had UICC stage I to III disease.  
 
Results: The overall anastomotic leak rate was 2.6% (13/500), 2.2% (11/500) for both 
clinical and radiological leaks, and 0.8% (2/254) for radiological leaks only. N=4 were 
managed conservatively, and n=9 (1.8%) required revision laparotomy. In the case of 
UICC stage IV disease, the anastomotic leak rate was 6.3% (6/94); in the case of 
UICC stage I to III disease the leak rate was 1.7% (7/406). UICC stage IV disease 
(odds ratio 4.4, 95% confidence interval 1.3 - 14.4, p=0.015) and diabetes (odds ratio 
5.7, 95% confidence interval 1.7 - 18.7, p=0.004) remained independent risk factors 
for anastomotic leakage after colorectal surgery.  
 
Conclusions: Patients with stage IV colorectal cancer have an increased anastomotic 
leak rate after colorectal surgery. Whether this is due to impaired immune system 
remains speculation.   
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Introduction 
One in five patient with diagnosed colorectal cancer has synchronous liver 
metastasis and only a minority qualifies for curative liver resection 1. Different 
treatment strategies in the palliative and in the curative setting are under debate 2-8. 
However, surprisingly little is known on the specific risks of colorectal surgery in 
patients with metastatic colorectal cancer. 
We aimed to determine if metastatic colorectal cancer (UICC stage IV disease) itself 
represents a risk factor for anastomotic leakage after colonic or rectal anastomosis 
without major hepatic resection and to compare it to other known risk factors of 
anastomotic leakage. 
 
Methods 
This retrospective cohort study is based on an existing prospective colorectal 
database with all consecutive colorectal resections done at the authors’ institution 
from 07/2002 to 07/2012 (n=2104). As different hospitals are located near the 
authors’ institution the study is not population based. Patients with colorectal 
resections without colonic or rectal anastomosis (n=229) were excluded. From the 
remaining n=1875 patients, those with the following procedures were excluded: 
reversal of hartmann’s procedure (n=70), redo of anastomosis for anastomotic leak 
(n=7), colon resection and primary anastomosis for the following diseases: 
diverticular disease (n=661), colorectal adenoma (n=111), rectal prolapse (n=122), 
non-colorectal cancer (n=101), complicated appendicitis (n=63), chronic inflammatory 
bowel disease (n=58), ischemic or infectious colitis (n=44), iatrogenic or traumatic 
colon perforation (n=37), non-malignant large bowel obstruction (including 
anastomotic stenosis, radiation injuries, incarcerated hernia n=30), slow-transit 
constipation (n=22), volvulus (n=11),  Ogilvie’s syndrome with severe colonic 
Page 3 of 37
To contact the Journal office: info@asoeditorial.org
Annals of Surgical Oncology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 4 
damage (n=10), colonic bleeding (n=22), and other reasons (n=6). Finally, n=500 
patients with colorectal resection and primary anastomosis for colorectal cancer were 
included in the study.  
The routine preoperative workup comprised CT scan of the abdomen and 
conventional X-ray or CT scan of the thorax. In the case of suspicion of liver 
metastasis MRI and intraoperative ultrasound were done. 
A temporary loop ileostomy was always constructed in low rectal anastomosis up to 6 
cm from anal verge (n=128 cases; 26%). 
The laboratory values measured one day before surgery were assessed. 
Extravasation of water-soluble contrast medium in conventional contrast enema or 
CT scan, abscesses near the colonic or rectal anastomosis without extravasation of 
contrast medium, and anastomotic leaks diagnosed during surgical re-intervention in 
presence of obvious signs of an anastomotic leak such as fecal abdominal drainage 
were accounted as an anastomotic leak. The patients were observed clinically and by 
routine inflammation markers during hospitalization for several days. However, in the 
case of unexpected postoperative course after sending home the patients, they 
reliably were sent back to the present surgical unit for further treatment. 
Routine contrast enema was done at the occasion of other prospective studies 
(n=254), especially in all patients with temporary loop ileostomy (n=131). In the 
remaining patients (n=246) contrast enema was only done in the case of suspicion of 
an anastomotic leak. 
UICC stage IV disease was present in n=94 patients (19%), while n=406 (81%) had 
UICC stage I to III disease. An overview of the study methodology is shown in Figure 
1. 
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Statistics: Results are expressed as median and range or mean and standard 
deviation whenever appropriate. Categorical data was analyzed with the two-sided 
Fisher’s exact test and Pearson’s Chi Square if the contingency table was larger than 
2x2. Continuous data was analyzed with the Wilcoxon rank sum test. Multivariate 
analyses were done by logistic regression. P-values < 0.05 were considered 
statistically significant.  
Ethics statement: The present study is a retrospective observational study without 
any experimental protocols and thus no potential harm for patients. 
 
Results 
The only significant difference in the patients’ characteristics between patients with 
stage I-III to patients with stage IV colorectal cancer was the ASA (American Society 
of Anesthesiologists) score as shown in table 1. The distribution of metastases in 
patients with metastatic disease (n=94) was: 49% (n=46) liver only, 3% (n=3) lung 
only, 3% (n=3) peritoneal only, 3% (n=3) retroperitoneal only, 12% (n=11) liver and 
lung only, 12% (n=11) peritoneal and liver only, 1% (n=1) retroperitoneal and lung 
only, and 17% (n=16) multiorgan disease.  
Patients with metastatic disease were treated with a curative intention in 42.5% 
(n=40), while 41.5% (n=39) had a planned palliative therapy and the remaining 16% 
(n=15) had palliative best supportive care due to their poor general state.  
 
The anastomotic leaks were diagnosed on median postoperative day 6 (range 1-15). 
The overall anastomotic leak rate was 2.6% (13/500). Two of these thirteen 
anastomotic leaks were diagnosed by routine contrast enema and remained 
subclinical i.e. without symptoms, two were managed conservatively, and nine 
required revision laparotomy.  
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It is noteworthy that three of the six patients with stage IV colorectal cancer who had 
anastomotic leakage were in a palliative setting. 
 
The analyzed and detected risk factors for the development of an anastomotic leak 
after resection of colon or rectal cancer (univariate) are shown in Table 2. The results 
of the multivariate analyses comparing the detected risk factors for the development 
of an anastomotic leak after resection of colon or rectal cancer are shown in Table 3; 
stage IV colorectal cancer and diabetes remained statistically significant risk factors 
for the development of an anastomotic leak, while male gender and resection of left-
sided colon cancer or rectal cancer did not.  
The leak rate of patients with and without UICC stage IV colorectal cancer is depicted 
in Figure 2. The leak rate was 9% (6/63) in patients with diabetes mellitus and 1.6% 
(7/437) without. 
 
Subgroup analyses: colon cancer 
From n=339 patients with colon cancer, n=10 had anastomotic leakage (2.9%). With 
respect to the type of surgery the leak rates were as following: left hemicolectomy 
6.7% (8/137); subtotal colectomy (1/31); transverse resection (0/5), right 
hemicolectomy 0.6% (1/166). 
Univariate analysis revealed that stage IV disease (p=0.006), left colon cancer 
(p=0.010), and male gender (p=0.023) were statistically significant predictors of 
anastomotic leakage after resection of colon cancer, while the other analyzed factors 
were not. Multivariate analyses with the detected significant predictors of anastomotic 
leakage showed that stage IV disease (p=0.003, Odds ratio 7.6 [95% confidence 
interval: 2.0 – 29.4]), left-sided colon cancer (p=0.025, Odds ratio 11.1 [95% 
confidence interval: 1.3 – 91.8]), and male gender (p=0.045, Odds ratio 8.7 [95% 
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confidence interval: 1.0 – 71.5]) remained independent statistically significant 
predictors of anastomotic leakage after resection of colon cancer. 
Subgroup analyses: rectal cancer 
From n=161 patients with rectal cancer, n=3 patients had anastomotic leakage 
(1.9%). In patients with high anterior recto-sigmoid resection with partial mesorectal 
excision without loop ileostomy for cancer of the upper third of the rectum (n=30) no 
leak occured, while in those patients with low anterior rectal resection with loop 
ileostomy for cancer of the lower two thirds of the rectum (n=128) or with high 
anterior recto-sigmoid resection with loop ileostomy (n=3) the leak rate was 2.3% 
(3/131).  
Univariate analysis revealed that diabetes (p=0.001) and a lower preoperative 
hemoglobin value (p=0.023) were statistically significant predictors of anastomotic 
leakage, while the other analyzed factors were not. Multivariate analyses with the two 
detected significant predictors of anastomotic leakage showed that diabetes (p<0.001 
Odds ratio 7.7E8 [95% confidence interval: 11.9E3 – 5.0E13]) remained a statistically 
significant predictor of anastomotic leakage while a lower preoperative hemoglobin 
value (p=0.143 Odds ratio 0.5 [95% confidence interval: 0.2 – 1.3]) did not. 
 
Discussion 
Surprisingly little is known on the risks of colorectal surgery in patients with 
metastatic colorectal cancer. This study shows that metastatic colorectal cancer 
(UICC stage IV disease) itself is a risk factor for anastomotic leakage after colorectal 
surgery without major hepatic resection. Is this finding plausible? 
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First it is known that liver metastasis leads to an altered immune response 9,10. 
Immunosuppression as induced by steroids is a well-known risk factor for the 
development of an anastomotic leak after colorectal surgery 11. 
Second up to 65% of the patients with grade IV colorectal cancer have malnutrition 
12, and patients with malnutrition also have an altered immune response with an 
exaggerated Interleukin-6 and a suppressed Interleukin-1 response 13,14. A low level 
of Interleukin-1-receptor-antagonist is a known risk factor for adverse outcome after 
colorectal surgery 15.  
Besides metastatic colorectal cancer as a risk factor for anastomotic leakage, 
diabetes was identified as a second risk factor for anastomotic leakage. Diabetes is a 
known risk factor for delayed wound healing 18 and thus it can be assumed to be a 
risk factor for anastomotic leakage after colorectal surgery as well. Indeed some 
studies identified diabetes as a risk factor for anastomotic leakage after colorectal 
surgery 19,20, while others did not 21,22. Subgroup analyses revealed that in this study 
diabetes only remained a risk factor for anastomotic leakage in patients with rectal 
cancer. However, further research is needed to confirm if diabetes is a risk factor for 
anastomotic leakage after colorectal surgery or not. 
 
Subgroup analyses of those patients with resection of left-sided colon cancer had a 
significant higher leakage rate than those with right-sided colorectal cancer. This is 
known from literature16,17. We draw the conclusion that the construction of a 
temporary loop ileostomy should be considered in patients with left-sided stage IV 
colon cancer.  
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Subgroup analyses also identified male gender as a significant risk factor for 
anastomotic leakage in patients with resection for colon cancer, as known from 
literature23. 
 
Limitations 
The treatment policy for patients with stage IV colorectal cancer was to do the 
colorectal resection if feasible and safe. As mentioned above the study is not 
population based. Thus a patient selection bias with a selection of those patients in a 
better general state is possible. However, if more patients in a worse general state 
with an expected higher leakage rate would have been included, it can be assumed 
that stage IV disease would have turned out to be an even stronger predictor of 
anastomotic leakage. 
As only about half of the patients were investigated by routine radiology (n=254) few 
subclinical anastomotic leaks could have been missed in those patients who did not 
have routine radiology (n=246). As one of the two patients with a subclinical leak had 
stage I cancer and the other had stage IV cancer a bias is not expected. 
 
This study has a retrospective design. Thus, a further bias cannot be excluded. 
However, a bias was minimized by including all consecutive patients registered in a 
prospective database who had colorectal resection at the same institution in a 
predefined period of ten years.  
To confirm the results of this study and to prove the value of a routine temporary loop 
ileostomy in patients with left-sided stage IV colon cancer a prospective randomized 
trial is required. 
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Conclusion 
Patients with stage IV colorectal cancer have an increased leak rate after colonic or 
rectal anastomosis. Whether this is due to impaired immune system remains 
speculation.  
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Table 1 Patients’ characteristics 
Risk factor Stage I - III 
colorectal cancer 
(n=406) 
Stage IV colorectal 
cancer 
 (n=94) 
p-value 
Mean age (SD) 70 (12) years  69 (12) years 0.190 
Male gender n=237/406 n=53/94 0.729 
Median ASA Score 
(Range) 
2 (1-5) 3 (1-4) 0.012 
Cardiac comorbidities n=204/356 (57%) n=55/85 (65%) 0.372 
Vascular comorbidities n=41/342 (12%) n=6/85 (7%) 0.327 
Diabetes n=54/356 (15%) n=9/85 (11%) 0.388 
Pulmonary comorbidities n=55/356 (15%) n=18/85 (21%) 0.198 
Tobacco abuse n=48/356 (13%) n=15/85 (18%) 0.307 
Obesity n=195/356 (55%) n=54/85 (64%) 0.180 
Dementia n=12/355 (3%) n=0/85 (0%) 0.135 
Immunosuppressive 
drugs 
n=6/352 (2%) n=2/85 (2%) 0.656 
Non-steroidal anti-
inflammatory drugs 
n=62/352 (18%) n=13/85 (15%) 0.749 
Presence of peritonitis n=22/329 (7%) n=5/85 (6%) 1.000 
Large bowel obstruction n=37/351 (11%) n=10/85 (12%) 0.700 
Urgent surgery n=49/351 (14%) n=12/85 (15%) 1.000 
SD: standard deviation, ASA: American Society of Anesthesiologists 
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Table 2 Results of the univariate analyses of the risk factors of anastomotic leakage 
after colorectal surgery for colorectal cancer. 
Risk factor Anastomotic leak  
(n=13) 
No anastomotic leak 
(n=487) 
p-value 
Mean age (SD) 73 (8) years 70 (12) years 0.516 
Male gender 12/13 278/487 (57%) 0.010 
Median ASA Score 
(Range) 
2 (1-3) 2 (1-5) 0.657 
Cardiac comorbidities 9/13 250/428 (58%) 0.584 
Vascular comorbidities 2/13 45/428 (11%) 0.638 
Diabetes 6/13 57/428 (13%) 0.005 
Pulmonary comorbidities 1/13 72/428 (17%) 0.704 
Tobacco abuse 2/13 61/428 (14%) 1.000 
Obesity 8/13 241/428 (56%) 0.783 
Dementia 0/13 12/427 (3%) 1.000 
Immunosuppressive 
drugs 
0/13 8/424 (2%) 1.000 
Non-steroidal anti-
inflammatory drugs 
3/13 72/424 (17%) 0.475 
Preoperative radio- 
and/or chemotherapy 
0/13 43/472 (9%) 0.617 
Presence of peritonitis 0/13 27/396 (7%) 1.000 
Large bowel obstruction 1/13 46/377 (12%) 1.000 
Urgent surgery 1/13 60/396 (15%) 0.702 
ypT0 or T1 cancer 2/13 52/487 (11%)  
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T2 cancer 4/13  73/487 (15%)  
T3 cancer 3/13 245/487 (50%)  
T4 cancer 4/13 117/487 (24%) 0.218 
Nodal positive cancer  8/13 219/473 (46%) 0.270 
Stage IV colorectal 
cancer 
6/13 88/487 (18%) 0.021 
Resection of left-sided 
colon cancer or rectal 
cancer  
12/13 317/487 (65%) 0.0417 
Preoperative mean (SD) 
white blood cell count 
(1/10E9) 
8.0 (3.5) 7.7 (3.0) 0.629 
Preoperative mean (SD) 
Hemoglobin  
12.6 (2.0) 12.8 (2.1) 0.814 
Preoperative mean (SD) 
Sodium 
138.5 (2.9) 139.7 (3.1) 0.0935 
Preoperative mean (SD) 
Potassium  
4.3 (0.4) 4.1 (0.4) 0.324 
Preoperative mean (SD) 
Creatinine  
82.8 (23.8) 79.7 (40.8) 0.328 
Preoperative mean (SD) 
Albumin 
38 (4.0) 39.3 (5.5) 0.1872 
SD: standard deviation, ASA: American Society of Anesthesiologists 
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Table 3 Results of the multivariate analyses of the detected risk factors for 
anastomotic leakage after colorectal surgery for colorectal cancer. 
Risk factor Odds ratio 95%confidence 
interval 
p-value 
Diabetes 5.7 1.7 – 18.7 0.004 
Stage IV colorectal cancer 4.4 1.3 – 14.4 0.015 
Male gender 7.8 1.0 – 62.6 0.052 
Resection of left-sided colorectal 
cancer or rectal cancer 
6.7 0.8 – 53.0 0.073 
ASA: American Society of Anesthesiologists 
 
Figure 1: Flow diagram of the study methodology 
Figure 2: Anastomotic leakage rate in Stage I to III versus Stage IV colorectal cancer 
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Synopsis: Patients with resection for stage IV colorectal cancer have an increased 
anastomotic leak rate. 
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Abstract 
Purpose: To investigate if metastatic colorectal cancer (UICC stage IV disease) 
represents a risk factor for anastomotic leakage after colorectal surgery without major 
hepatic resection. 
 
Methods: This retrospective cohort study is based on an existing prospective 
colorectal database with all consecutive colorectal resections done at the authors’ 
institution from 07/2002 to 07/2012 (n=2104). All patients with colorectal resection 
and primary anastomosis for colorectal cancer were identified (n=500). A temporary 
loop ileostomy was constructed in low rectal anastomosis up to 6 cm from anal verge 
(n=128 cases; 26%). Routine contrast enema was done at the occasion of other 
prospective studies (n=254). UICC stage IV disease was present in n=94 patients 
(19%), while n=406 (81%) had UICC stage I to III disease.  
 
Results: The overall anastomotic leak rate was 2.6% (13/500), 2.2% (11/500) for 
both clinical and radiological leaks, and 0.8% (2/254) for radiological leaks 
only. N=4 were managed conservatively, and n=9 (1.8%) required revision 
laparotomy. In the case of UICC stage IV disease, the anastomotic leak rate was 
6.3% (6/94); in the case of UICC stage I to III disease the leak rate was 1.7% (7/406). 
UICC stage IV disease (odds ratio 4.4, 95% confidence interval 1.3 - 14.4, 
p=0.015) and diabetes (odds ratio 5.7, 95% confidence interval 1.7 - 18.7, 
p=0.004) remained independent risk factors for anastomotic leakage after 
colorectal surgery.  
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Conclusions: Patients with stage IV colorectal cancer have an increased anastomotic 
leak rate after colorectal surgery. Whether this is due to impaired immune system 
remains speculation.  
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Introduction 
One in five patient with diagnosed colorectal cancer has synchronous liver 
metastasis and only a minority qualifies for curative liver resection 1. Different 
treatment strategies in the palliative and in the curative setting are under debate 2-8. 
However, surprisingly little is known on the specific risks of colorectal surgery in 
patients with metastatic colorectal cancer. 
We aimed to determine if metastatic colorectal cancer (UICC stage IV disease) itself 
represents a risk factor for anastomotic leakage after colonic or rectal anastomosis 
without major hepatic resection and to compare it to other known risk factors of 
anastomotic leakage. 
 
Methods 
This retrospective cohort study is based on an existing prospective colorectal 
database with all consecutive colorectal resections done at the authors’ institution 
from 07/2002 to 07/2012 (n=2104). As different hospitals are located near the 
authors’ institution the study is not population based. Patients with colorectal 
resections without colonic or rectal anastomosis (n=229) were excluded. From the 
remaining n=1875 patients, those with the following procedures were excluded: 
reversal of hartmann’s procedure (n=70), redo of anastomosis for anastomotic leak 
(n=7), colon resection and primary anastomosis for the following diseases: 
diverticular disease (n=661), colorectal adenoma (n=111), rectal prolapse (n=122), 
non-colorectal cancer (n=101), complicated appendicitis (n=63), chronic inflammatory 
bowel disease (n=58), ischemic or infectious colitis (n=44), iatrogenic or traumatic 
colon perforation (n=37), non-malignant large bowel obstruction (including 
anastomotic stenosis, radiation injuries, incarcerated hernia n=30), slow-transit 
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constipation (n=22), volvulus (n=11),  Ogilvie’s syndrome with severe colonic 
damage (n=10), colonic bleeding (n=22), and other reasons (n=6). Finally, n=500 
patients with colorectal resection and primary anastomosis for colorectal cancer were 
included in the study.  
The routine preoperative workup comprised CT scan of the abdomen and 
conventional X-ray or CT scan of the thorax. In the case of suspicion of liver 
metastasis MRI and intraoperative ultrasound were done. 
A temporary loop ileostomy was always constructed in low rectal anastomosis up to 6 
cm from anal verge (n=128 cases; 26%). 
The laboratory values measured one day before surgery were assessed. 
Extravasation of water-soluble contrast medium in conventional contrast enema or 
CT scan, abscesses near the colonic or rectal anastomosis without extravasation of 
contrast medium, and anastomotic leaks diagnosed during surgical re-intervention in 
presence of obvious signs of an anastomotic leak such as fecal abdominal drainage 
were accounted as an anastomotic leak. The patients were observed clinically and by 
routine inflammation markers during hospitalization for several days. However, in the 
case of unexpected postoperative course after sending home the patients, they 
reliably were sent back to the present surgical unit for further treatment. 
Routine contrast enema was done at the occasion of other prospective studies 
(n=254), especially in all patients with temporary loop ileostomy (n=131). In the 
remaining patients (n=246) contrast enema was only done in the case of suspicion of 
an anastomotic leak. 
UICC stage IV disease was present in n=94 patients (19%), while n=406 (81%) had 
UICC stage I to III disease. An overview of the study methodology is shown in Figure 
1. 
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Statistics: Results are expressed as median and range or mean and standard 
deviation whenever appropriate. Categorical data was analyzed with the two-sided 
Fisher’s exact test and Pearson’s Chi Square if the contingency table was larger than 
2x2. Continuous data was analyzed with the Wilcoxon rank sum test. Multivariate 
analyses were done by logistic regression. P-values < 0.05 were considered 
statistically significant.  
Ethics statement: The present study is a retrospective observational study without 
any experimental protocols and thus no potential harm for patients. 
 
Results 
The only significant difference in the patients’ characteristics between patients with 
stage I-III to patients with stage IV colorectal cancer was the ASA (American Society 
of Anesthesiologists) score as shown in table 1. The distribution of metastases in 
patients with metastatic disease (n=94) was: 49% (n=46) liver only, 3% (n=3) lung 
only, 3% (n=3) peritoneal only, 3% (n=3) retroperitoneal only, 12% (n=11) liver and 
lung only, 12% (n=11) peritoneal and liver only, 1% (n=1) retroperitoneal and lung 
only, and 17% (n=16) multiorgan disease.  
Patients with metastatic disease were treated with a curative intention in 42.5% 
(n=40), while 41.5% (n=39) had a planned palliative therapy and the remaining 16% 
(n=15) had palliative best supportive care due to their poor general state.  
 
The anastomotic leaks were diagnosed on median postoperative day 6 (range 
1-15). The overall anastomotic leak rate was 2.6% (13/500). Two of these thirteen 
anastomotic leaks were diagnosed by routine contrast enema and remained 
subclinical i.e. without symptoms, two were managed conservatively, and nine 
required revision laparotomy.  
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It is noteworthy that three of the six patients with stage IV colorectal cancer who had 
anastomotic leakage were in a palliative setting. 
 
The analyzed and detected risk factors for the development of an anastomotic leak 
after resection of colon or rectal cancer (univariate) are shown in Table 2. The results 
of the multivariate analyses comparing the detected risk factors for the development 
of an anastomotic leak after resection of colon or rectal cancer are shown in Table 3; 
stage IV colorectal cancer and diabetes remained statistically significant risk factors 
for the development of an anastomotic leak, while male gender and resection of left-
sided colon cancer or rectal cancer did not.  
The leak rate of patients with and without UICC stage IV colorectal cancer is depicted 
in Figure 2. The leak rate was 9% (6/63) in patients with diabetes mellitus and 1.6% 
(7/437) without. 
 
Subgroup analyses: colon cancer 
From n=339 patients with colon cancer, n=10 had anastomotic leakage (2.9%). With 
respect to the type of surgery the leak rates were as following: left hemicolectomy 
6.7% (8/137); subtotal colectomy (1/31); transverse resection (0/5), right 
hemicolectomy 0.6% (1/166). 
Univariate analysis revealed that stage IV disease (p=0.006), left colon cancer 
(p=0.010), and male gender (p=0.023) were statistically significant predictors of 
anastomotic leakage after resection of colon cancer, while the other analyzed factors 
were not. Multivariate analyses with the detected significant predictors of anastomotic 
leakage showed that stage IV disease (p=0.003, Odds ratio 7.6 [95% confidence 
interval: 2.0 – 29.4]), left-sided colon cancer (p=0.025, Odds ratio 11.1 [95% 
confidence interval: 1.3 – 91.8]), and male gender (p=0.045, Odds ratio 8.7 [95% 
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confidence interval: 1.0 – 71.5]) remained independent statistically significant 
predictors of anastomotic leakage after resection of colon cancer. 
Subgroup analyses: rectal cancer 
From n=161 patients with rectal cancer, n=3 patients had anastomotic leakage 
(1.9%). In patients with high anterior recto-sigmoid resection with partial mesorectal 
excision without loop ileostomy for cancer of the upper third of the rectum (n=30) no 
leak occured, while in those patients with low anterior rectal resection with loop 
ileostomy for cancer of the lower two thirds of the rectum (n=128) or with high 
anterior recto-sigmoid resection with loop ileostomy (n=3) the leak rate was 2.3% 
(3/131).  
Univariate analysis revealed that diabetes (p=0.001) and a lower preoperative 
hemoglobin value (p=0.023) were statistically significant predictors of anastomotic 
leakage, while the other analyzed factors were not. Multivariate analyses with the two 
detected significant predictors of anastomotic leakage showed that diabetes (p<0.001 
Odds ratio 7.7E8 [95% confidence interval: 11.9E3 – 5.0E13]) remained a statistically 
significant predictor of anastomotic leakage while a lower preoperative hemoglobin 
value (p=0.143 Odds ratio 0.5 [95% confidence interval: 0.2 – 1.3]) did not. 
 
Discussion 
Surprisingly little is known on the risks of colorectal surgery in patients with 
metastatic colorectal cancer. This study shows that metastatic colorectal cancer 
(UICC stage IV disease) itself is a risk factor for anastomotic leakage after colorectal 
surgery without major hepatic resection. Is this finding plausible? 
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First it is known that liver metastasis leads to an altered immune response 9,10. 
Immunosuppression as induced by steroids is a well-known risk factor for the 
development of an anastomotic leak after colorectal surgery 11. 
Second up to 65% of the patients with grade IV colorectal cancer have malnutrition 
12, and patients with malnutrition also have an altered immune response with an 
exaggerated Interleukin-6 and a suppressed Interleukin-1 response 13,14. A low level 
of Interleukin-1-receptor-antagonist is a known risk factor for adverse outcome after 
colorectal surgery 15.  
Besides metastatic colorectal cancer as a risk factor for anastomotic leakage, 
diabetes was identified as a second risk factor for anastomotic leakage. Diabetes is a 
known risk factor for delayed wound healing 18 and thus it can be assumed to be a 
risk factor for anastomotic leakage after colorectal surgery as well. Indeed some 
studies identified diabetes as a risk factor for anastomotic leakage after colorectal 
surgery 19,20, while others did not 21,22. Subgroup analyses revealed that in this study 
diabetes only remained a risk factor for anastomotic leakage in patients with rectal 
cancer. However, further research is needed to confirm if diabetes is a risk factor for 
anastomotic leakage after colorectal surgery or not. 
 
Subgroup analyses of those patients with resection of left-sided colon cancer had a 
significant higher leakage rate than those with right-sided colorectal cancer. This is 
known from literature16,17. We draw the conclusion that the construction of a 
temporary loop ileostomy should be considered in patients with left-sided stage IV 
colon cancer.  
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Subgroup analyses also identified male gender as a significant risk factor for 
anastomotic leakage in patients with resection for colon cancer, as known from 
literature23. 
 
Limitations 
The treatment policy for patients with stage IV colorectal cancer was to do the 
colorectal resection if feasible and safe. As mentioned above the study is not 
population based. Thus a patient selection bias with a selection of those patients in a 
better general state is possible. However, if more patients in a worse general state 
with an expected higher leakage rate would have been included, it can be assumed 
that stage IV disease would have turned out to be an even stronger predictor of 
anastomotic leakage. 
As only about half of the patients were investigated by routine radiology 
(n=254) few subclinical anastomotic leaks could have been missed in those 
patients who did not have routine radiology (n=246). As one of the two patients 
with a subclinical leak had stage I cancer and the other had stage IV cancer a 
bias is not expected. 
 
This study has a retrospective design. Thus, a further bias cannot be excluded. 
However, a bias was minimized by including all consecutive patients registered in a 
prospective database who had colorectal resection at the same institution in a 
predefined period of ten years.  
To confirm the results of this study and to prove the value of a routine temporary loop 
ileostomy in patients with left-sided stage IV colon cancer a prospective randomized 
trial is required. 
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Conclusion 
Patients with stage IV colorectal cancer have an increased leak rate after colonic or 
rectal anastomosis. Whether this is due to impaired immune system remains 
speculation.  
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Table 1 Patients’ characteristics 
Risk factor Stage I - III 
colorectal cancer 
(n=406) 
Stage IV colorectal 
cancer 
 (n=94) 
p-value 
Mean age (SD) 70 (12) years  69 (12) years 0.190 
Male gender n=237/406 n=53/94 0.729 
Median ASA Score 
(Range) 
2 (1-5) 3 (1-4) 0.012 
Cardiac comorbidities n=204/356 (57%) n=55/85 (65%) 0.372 
Vascular comorbidities n=41/342 (12%) n=6/85 (7%) 0.327 
Diabetes n=54/356 (15%) n=9/85 (11%) 0.388 
Pulmonary comorbidities n=55/356 (15%) n=18/85 (21%) 0.198 
Tobacco abuse n=48/356 (13%) n=15/85 (18%) 0.307 
Obesity n=195/356 (55%) n=54/85 (64%) 0.180 
Dementia n=12/355 (3%) n=0/85 (0%) 0.135 
Immunosuppressive 
drugs 
n=6/352 (2%) n=2/85 (2%) 0.656 
Non-steroidal anti-
inflammatory drugs 
n=62/352 (18%) n=13/85 (15%) 0.749 
Presence of peritonitis n=22/329 (7%) n=5/85 (6%) 1.000 
Large bowel obstruction n=37/351 (11%) n=10/85 (12%) 0.700 
Urgent surgery n=49/351 (14%) n=12/85 (15%) 1.000 
SD: standard deviation, ASA: American Society of Anesthesiologists 
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Table 2 Results of the univariate analyses of the risk factors of anastomotic leakage 
after colorectal surgery for colorectal cancer. 
Risk factor Anastomotic leak  
(n=13) 
No anastomotic leak 
(n=487) 
p-value 
Mean age (SD) 73 (8) years 70 (12) years 0.516 
Male gender 12/13 278/487 (57%) 0.010 
Median ASA Score 
(Range) 
2 (1-3) 2 (1-5) 0.657 
Cardiac comorbidities 9/13 250/428 (58%) 0.584 
Vascular comorbidities 2/13 45/428 (11%) 0.638 
Diabetes 6/13 57/428 (13%) 0.005 
Pulmonary comorbidities 1/13 72/428 (17%) 0.704 
Tobacco abuse 2/13 61/428 (14%) 1.000 
Obesity 8/13 241/428 (56%) 0.783 
Dementia 0/13 12/427 (3%) 1.000 
Immunosuppressive 
drugs 
0/13 8/424 (2%) 1.000 
Non-steroidal anti-
inflammatory drugs 
3/13 72/424 (17%) 0.475 
Preoperative radio- 
and/or chemotherapy 
0/13 43/472 (9%) 0.617 
Presence of peritonitis 0/13 27/396 (7%) 1.000 
Large bowel obstruction 1/13 46/377 (12%) 1.000 
Urgent surgery 1/13 60/396 (15%) 0.702 
ypT0 or T1 cancer 2/13 52/487 (11%)  
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T2 cancer 4/13  73/487 (15%)  
T3 cancer 3/13 245/487 (50%)  
T4 cancer 4/13 117/487 (24%) 0.218 
Nodal positive cancer  8/13 219/473 (46%) 0.270 
Stage IV colorectal 
cancer 
6/13 88/487 (18%) 0.021 
Resection of left-sided 
colon cancer or rectal 
cancer  
12/13 317/487 (65%) 0.0417 
Preoperative mean (SD) 
white blood cell count 
(1/10E9) 
8.0 (3.5) 7.7 (3.0) 0.629 
Preoperative mean (SD) 
Hemoglobin  
12.6 (2.0) 12.8 (2.1) 0.814 
Preoperative mean (SD) 
Sodium 
138.5 (2.9) 139.7 (3.1) 0.0935 
Preoperative mean (SD) 
Potassium  
4.3 (0.4) 4.1 (0.4) 0.324 
Preoperative mean (SD) 
Creatinine  
82.8 (23.8) 79.7 (40.8) 0.328 
Preoperative mean (SD) 
Albumin 
38 (4.0) 39.3 (5.5) 0.1872 
SD: standard deviation, ASA: American Society of Anesthesiologists 
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Table 3 Results of the multivariate analyses of the detected risk factors for 
anastomotic leakage after colorectal surgery for colorectal cancer. 
Risk factor Odds ratio 95%confidence 
interval 
p-value 
Diabetes 5.7 1.7 – 18.7 0.004 
Stage IV colorectal cancer 4.4 1.3 – 14.4 0.015 
Male gender 7.8 1.0 – 62.6 0.052 
Resection of left-sided colorectal 
cancer or rectal cancer 
6.7 0.8 – 53.0 0.073 
ASA: American Society of Anesthesiologists 
 
Figure 1: Flow diagram of the study methodology 
Figure 2: Anastomotic leakage rate in Stage I to III versus Stage IV colorectal cancer 
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